Cargando…

Lactating Mother and Psychotropic Drugs

Usage of psychotropics during pregnancy and lactation has always been a topic of debate and controversy. The debate stems from the potential adverse effects on the growing fetus or infants due to the transfer of psychotropic drugs through placenta or breast milk of mothers receiving them; and the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tripathi, B. M., Majumder, Pradipta
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031938/
https://www.ncbi.nlm.nih.gov/pubmed/21327172
http://dx.doi.org/10.4103/0973-1229.58821
_version_ 1782197405138026496
author Tripathi, B. M.
Majumder, Pradipta
author_facet Tripathi, B. M.
Majumder, Pradipta
author_sort Tripathi, B. M.
collection PubMed
description Usage of psychotropics during pregnancy and lactation has always been a topic of debate and controversy. The debate stems from the potential adverse effects on the growing fetus or infants due to the transfer of psychotropic drugs through placenta or breast milk of mothers receiving them; and the problem of discontinuing psychotropics in lactating mother considering chances of relapse. However, most of the psychotropics are found to be relatively safe when used cautiously during the lactation phase. This article describes available data on the use of psychotropics in lactating mothers, in particular, in relation to the safety profile of infants.
format Text
id pubmed-3031938
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30319382011-02-15 Lactating Mother and Psychotropic Drugs Tripathi, B. M. Majumder, Pradipta Mens Sana Monogr Psychopharmacology Today Usage of psychotropics during pregnancy and lactation has always been a topic of debate and controversy. The debate stems from the potential adverse effects on the growing fetus or infants due to the transfer of psychotropic drugs through placenta or breast milk of mothers receiving them; and the problem of discontinuing psychotropics in lactating mother considering chances of relapse. However, most of the psychotropics are found to be relatively safe when used cautiously during the lactation phase. This article describes available data on the use of psychotropics in lactating mothers, in particular, in relation to the safety profile of infants. Medknow Publications 2010 /pmc/articles/PMC3031938/ /pubmed/21327172 http://dx.doi.org/10.4103/0973-1229.58821 Text en © Mens Sana Monographs http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Psychopharmacology Today
Tripathi, B. M.
Majumder, Pradipta
Lactating Mother and Psychotropic Drugs
title Lactating Mother and Psychotropic Drugs
title_full Lactating Mother and Psychotropic Drugs
title_fullStr Lactating Mother and Psychotropic Drugs
title_full_unstemmed Lactating Mother and Psychotropic Drugs
title_short Lactating Mother and Psychotropic Drugs
title_sort lactating mother and psychotropic drugs
topic Psychopharmacology Today
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031938/
https://www.ncbi.nlm.nih.gov/pubmed/21327172
http://dx.doi.org/10.4103/0973-1229.58821
work_keys_str_mv AT tripathibm lactatingmotherandpsychotropicdrugs
AT majumderpradipta lactatingmotherandpsychotropicdrugs